STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) CEO nets shares after 11,518 RSUs vest and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MariMed Inc. President and CEO Jon R. Levine reported routine equity compensation activity. On April 2, 2026 he exercised 11,518 Restricted Stock Units, receiving the same number of common shares at no cash cost as the RSUs convert one-for-one into stock.

To cover tax obligations tied to this vesting, 3,992 common shares were withheld by MariMed at a price of $0.0691 per share, leaving Levine with a net increase of 7,526 shares. After these transactions, he directly holds 21,158,974 common shares.

The filing also notes 6,684,640 common shares held by the Jon Levine Family Trust for the benefit of his spouse and children; Levine disclaims beneficial ownership of these trust shares. The RSUs were granted on April 2, 2024, with the remaining units scheduled to vest in equal installments on October 2, 2026 and April 2, 2027.

Positive

  • None.

Negative

  • None.
Insider Levine Jon R
Role President and CEO
Type Security Shares Price Value
Exercise Restricted Stock Units (RSU) 11,518 $0.00 --
Exercise Common stock 11,518 $0.00 --
Tax Withholding Common stock 3,992 $0.0691 $275.85
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 23,034 shares (Direct); Common stock — 21,162,966 shares (Direct); Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in two equal installments on each of October 2, 2026 and April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
RSUs exercised 11,518 RSUs Converted one-for-one into common stock on April 2, 2026
Shares withheld for taxes 3,992 shares at $0.0691 Common stock withheld to satisfy RSU tax obligations
Direct common shares after transactions 21,158,974 shares Jon R. Levine direct ownership following April 2, 2026 events
Family trust holdings 6,684,640 shares Held by the Jon Levine Family Trust; beneficial ownership disclaimed
RSU grant date April 2, 2024 Grant date for RSUs that partially vested on April 2, 2026
Restricted Stock Units (RSU) financial
"Restricted Stock Units (RSU) convert to shares of common stock on a one-for-one basis."
tax withholding obligations financial
"Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs."
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
family trust financial
"These shares are held in trust for the benefit of the Reporting Person's spouse and children."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levine Jon R
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD, MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock04/02/2026M11,518A$0(1)21,162,966D
Common stock04/02/2026F3,992(2)D$0.069121,158,974D
Common stock6,684,640IBy the Jon Levine Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)04/02/2026M11,518 (4) (4)Common Stock, par value $.001 per share11,518$023,034D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. These RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in two equal installments on each of October 2, 2026 and April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Jon R. Levine04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MariMed (MRMD) CEO Jon Levine report?

Jon Levine reported exercising 11,518 Restricted Stock Units into common stock and a related tax share withholding. This was a routine equity compensation vesting, not an open-market purchase or sale, and increased his direct common stock holdings after netting out shares withheld for taxes.

How many MariMed (MRMD) shares does Jon Levine hold after this Form 4?

After the reported transactions, Jon Levine directly holds 21,158,974 shares of MariMed common stock. The filing also references 6,684,640 shares held by the Jon Levine Family Trust, for the benefit of his spouse and children, for which he disclaims beneficial ownership.

What was the purpose of the 3,992 MariMed (MRMD) shares withheld?

The 3,992 common shares were withheld by MariMed to satisfy tax withholding obligations arising from the vesting of RSUs. Instead of paying cash for taxes, a portion of the newly vested shares was used, which reduces the net number of shares Levine retained from the vesting.

Are Jon Levine’s MariMed (MRMD) RSUs fully vested after this filing?

No. The RSUs exercised here vest only part of a larger grant awarded on April 2, 2024. According to the filing, the remaining RSUs from this grant will vest in two equal installments on October 2, 2026 and April 2, 2027, per the award agreement.

What does Jon Levine’s family trust holding mean for MariMed (MRMD) ownership?

The filing notes 6,684,640 MariMed shares held by the Jon Levine Family Trust for his spouse and children. Levine disclaims beneficial ownership of these securities. This means he does not treat them as his own holdings for Section 16 or other beneficial ownership purposes.

Was this MariMed (MRMD) insider transaction an open-market trade?

No. The Form 4 shows a derivative exercise of RSUs and a tax-withholding disposition, not open-market buying or selling. Shares were issued at no cash exercise price, and some were withheld to cover taxes, making this a routine compensation and tax event.